Evidence of a Role of Tumor Necrosis Factor {alpha} in Refractory Asthma

doi:10.1056/NEJMoa050580

Volume 354:697-708		February 16, 2006		Number 7

Evidence of a Role of Tumor Necrosis Factor ${alpha}$ in Refractory Asthma

Mike A. Berry, M.R.C.P., Beverley Hargadon, R.G.N., Maria Shelley, R.G.N., B.A., Debbie Parker, B.Sc., Dominick E. Shaw, M.R.C.P., Ruth H. Green, M.D., M.R.C.P., Peter Bradding, D.M., F.R.C.P., Christopher E. Brightling, Ph.D., M.R.C.P., Andrew J. Wardlaw, Ph.D., F.R.C.P., and Ian D. Pavord, D.M., F.R.C.P.

Full Text

PDF

PDA Full Text

PowerPoint Slide Set

Supplementary Material

Editorial
by Erzurum, S. C.

Letters

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

E-mail When Letters Appear

PubMed Citation

ABSTRACT

Background The development of tumor necrosis factor ${alpha}$ (TNF- ${alpha}$ )antagonists has made it feasible to investigate the role ofthis cytokine in refractory asthma.

Methods We measured markers of TNF- ${alpha}$ activity on peripheral-bloodmonocytes in 10 patients with refractory asthma, 10 patientswith mild-to-moderate asthma, and 10 control subjects. We alsoinvestigated the effects of treatment with the soluble TNF- ${alpha}$ receptor etanercept (25 mg twice weekly) in the patients withrefractory asthma in a placebo-controlled, double-blind, crossoverpilot study.

Results As compared with patients with mild-to-moderate asthmaand controls, patients with refractory asthma had increasedexpression of membrane-bound TNF- ${alpha}$ , TNF- ${alpha}$ receptor 1, and TNF- ${alpha}$ –convertingenzyme by peripheral-blood monocytes. In the clinical trial,as compared with placebo, 10 weeks of treatment with etanerceptwas associated with a significant increase in the concentrationof methacholine required to provoke a 20 percent decrease inthe forced expiratory volume in one second (FEV₁) (mean differencein doubling concentration changes between etanercept and placebo,3.5; 95 percent confidence interval, 0.07 to 7.0; P=0.05), animprovement in the asthma-related quality-of-life score (by0.85 point; 95 percent confidence interval, 0.16 to 1.54 ona 7-point scale; P=0.02), and a 0.32-liter increase in post-bronchodilatorFEV₁ (95 percent confidence interval, 0.08 to 0.55; P=0.01).

Conclusions Patients with refractory asthma have evidence ofup-regulation of the TNF- ${alpha}$ axis. (ClinicalTrials.gov number,NCT00276029 [ClinicalTrials.gov] .)

Source Information

From the Institute for Lung Health, University Hospital of Leicester National Health Service Trust, Glenfield Hospital, Leicester, United Kingdom.

Address reprint requests to Prof. Pavord at the Institute for Lung Health, University Hospital of Leicester National Health Service Trust, Glenfield Hospital, Groby Rd., Leicester LE3 9QP, United Kingdom, or at ian.pavord{at}uhl-tr.nhs.uk.

Full Text of this Article

Related Letters:

Tumor Necrosis Factor ${alpha}$ in Refractory Asthma
Oliveri C., Polosa R., Berry M. A., Pavord I. D.
Extract | Full Text | PDF
N Engl J Med 2006; 354:2074-2075, May 11, 2006. Correspondence

This article has been cited by other articles:

Prefontaine, D., Lajoie-Kadoch, S., Foley, S., Audusseau, S., Olivenstein, R., Halayko, A. J., Lemiere, C., Martin, J. G., Hamid, Q. (2009). Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells. J. Immunol. 183: 5094-5103 [Abstract] [Full Text]
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., Fahy, J. V. (2009). T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma. Am. J. Respir. Crit. Care Med. 180: 388-395 [Abstract] [Full Text]
Creed, T. J., Lee, R. W., Newcomb, P. V., di Mambro, A. J., Raju, M., Dayan, C. M. (2009). The Effects of Cytokines on Suppression of Lymphocyte Proliferation by Dexamethasone. J. Immunol. 183: 164-171 [Abstract] [Full Text]
Humbert, M. (2009). Biologics in severe difficult-to-treat asthma: find the right niche!. ERR 18: 51-53 [Full Text]
Gaga, M., Zervas, E., Chanez, P. (2009). Update on severe asthma: what we know and what we need. ERR 18: 58-65 [Full Text]
Lemanske, R. F. Jr. (2009). Asthma Therapies Revisited: What Have We Learned?. Proc Am Thorac Soc 6: 312-315 [Abstract] [Full Text]
Wenzel, S. E., Barnes, P. J., Bleecker, E. R., Bousquet, J., Busse, W., Dahlen, S.-E., Holgate, S. T., Meyers, D. A., Rabe, K. F., Antczak, A., Baker, J., Horvath, I., Mark, Z., Bernstein, D., Kerwin, E., Schlenker-Herceg, R., Lo, K. H., Watt, R., Barnathan, E. S., Chanez, P., on behalf of the T03 Asthma Investigators, (2009). A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-{alpha} Blockade in Severe Persistent Asthma. Am. J. Respir. Crit. Care Med. 179: 549-558 [Abstract] [Full Text]
Horiuchi, K., Kimura, T., Miyamoto, T., Miyamoto, K., Akiyama, H., Takaishi, H., Morioka, H., Nakamura, T., Okada, Y., Blobel, C. P., Toyama, Y. (2009). Conditional Inactivation of TACE by a Sox9 Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF. J. Immunol. 182: 2093-2101 [Abstract] [Full Text]
Van Lieshout, R. J., Bienenstock, J., MacQueen, G. M. (2009). A Review of Candidate Pathways Underlying the Association Between Asthma and Major Depressive Disorder. Psychosom. Med. 71: 187-195 [Abstract] [Full Text]
Braman, S. S. (2009). Asthma. ACCP Pulmonary Med Brd Rev 25: 81-112 [Full Text]
Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S.-i., Suto, A., Watanabe, N., Saito, Y., Hatano, M., Tokuhisa, T., Iwakura, Y., Puccetti, P., Iwamoto, I., Nakajima, H. (2008). IL-23 and Th17 Cells Enhance Th2-Cell-mediated Eosinophilic Airway Inflammation in Mice. Am. J. Respir. Crit. Care Med. 178: 1023-1032 [Abstract] [Full Text]
Sterk, P. J., Yick, C. Y., Slats, A. M. (2008). The secret life of steroids in asthma. Eur Respir J 32: 1135-1137 [Full Text]
Ito, K., Herbert, C., Siegle, J. S., Vuppusetty, C., Hansbro, N., Thomas, P. S., Foster, P. S., Barnes, P. J., Kumar, R. K. (2008). Steroid-Resistant Neutrophilic Inflammation in a Mouse Model of an Acute Exacerbation of Asthma. Am. J. Respir. Cell Mol. Bio. 39: 543-550 [Abstract] [Full Text]
Sin, D D, Sutherland, E R (2008). Obesity and the lung: 4 {middle dot} Obesity and asthma. Thorax 63: 1018-1023 [Abstract] [Full Text]
Burgel, P-R., Nadel, J. A. (2008). Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 32: 1068-1081 [Abstract] [Full Text]
Sutherland, E. R., Goleva, E., Strand, M., Beuther, D. A., Leung, D. Y. M. (2008). Body Mass and Glucocorticoid Response in Asthma. Am. J. Respir. Crit. Care Med. 178: 682-687 [Abstract] [Full Text]
Adcock, I. M., Barnes, P. J. (2008). Molecular Mechanisms of Corticosteroid Resistance. Chest 134: 394-401 [Abstract] [Full Text]
Berry, M. A, Pavord, I. D (2008). Antagonism of tumour necrosis factor {alpha} in refractory asthma. Thorax 63: 571-572 [Full Text]
Morjaria, J B, Chauhan, A J, Babu, K S, Polosa, R, Davies, D E, Holgate, S T (2008). The role of a soluble TNF{alpha} receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial. Thorax 63: 584-591 [Abstract] [Full Text]
Chmura, K., Bai, X., Nakamura, M., Kandasamy, P., McGibney, M., Kuronuma, K., Mitsuzawa, H., Voelker, D. R., Chan, E. D. (2008). Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L220-L230 [Abstract] [Full Text]
Janssen, R, Krivokuca, I, Kruize, A A, Koenderman, L, Lammers, J-W J (2008). Adalimumab-induced bronchospasm: not a class effect. Thorax 63: 472-473 [Full Text]
Lee, C.-W., Lin, C.-C., Luo, S.-F., Lee, H.-C., Lee, I.-T., Aird, W. C., Hwang, T.-L., Yang, C.-M. (2008). Tumor Necrosis Factor-{alpha} Enhances Neutrophil Adhesiveness: Induction of Vascular Cell Adhesion Molecule-1 via Activation of Akt and CaM Kinase II and Modifications of Histone Acetyltransferase and Histone Deacetylase 4 in Human Tracheal Smooth Muscle Cells. Mol. Pharmacol. 73: 1454-1464 [Abstract] [Full Text]
Hanania, N. A. (2008). Targeting Airway Inflammation in Asthma: Current and Future Therapies. Chest 133: 989-998 [Abstract] [Full Text]
Reuter, S., Heinz, A., Sieren, M., Wiewrodt, R., Gelfand, E. W., Stassen, M., Buhl, R., Taube, C. (2008). Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J 31: 773-782 [Abstract] [Full Text]
Matsuda, A., Fukuda, S., Matsumoto, K., Saito, H. (2008). Th1/Th2 Cytokines Reciprocally Regulate In Vitro Pulmonary Angiogenesis via CXC Chemokine Synthesis. Am. J. Respir. Cell Mol. Bio. 38: 168-175 [Abstract] [Full Text]
Oyoshi, M. K., Bryce, P., Goya, S., Pichavant, M., Umetsu, D. T., Oettgen, H. C., Tsitsikov, E. N. (2008). TNF Receptor-Associated Factor 1 Expressed in Resident Lung Cells Is Required for the Development of Allergic Lung Inflammation. J. Immunol. 180: 1878-1885 [Abstract] [Full Text]
Guedes, A. G. P., Jude, J. A., Paulin, J., Kita, H., Lund, F. E., Kannan, M. S. (2008). Role of CD38 in TNF-{alpha}-induced airway hyperresponsiveness. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L290-L299 [Abstract] [Full Text]
Erin, E. M., Jenkins, G. R., Kon, O. M., Zacharasiewicz, A. S., Nicholson, G. C., Neighbour, H., Tennant, R. C., Tan, A. J., Leaker, B. R., Bush, A., Jose, P. J., Barnes, P. J., Hansel, T. T. (2008). Optimized Dialysis and Protease Inhibition of Sputum Dithiothreitol Supernatants. Am. J. Respir. Crit. Care Med. 177: 132-141 [Abstract] [Full Text]
Jude, J. A., Wylam, M. E., Walseth, T. F., Kannan, M. S. (2008). Calcium Signaling in Airway Smooth Muscle. Proc Am Thorac Soc 5: 15-22 [Abstract] [Full Text]
Elizur, A., Adair-Kirk, T. L., Kelley, D. G., Griffin, G. L., deMello, D. E., Senior, R. M. (2008). Tumor Necrosis Factor-{alpha} from Macrophages Enhances LPS-Induced Clara Cell Expression of Keratinocyte-Derived Chemokine. Am. J. Respir. Cell Mol. Bio. 38: 8-15 [Abstract] [Full Text]
Ware, L. B. (2007). Clinical Year in Review III: Asthma, Lung Transplantation, Cystic Fibrosis, Acute Respiratory Distress Syndrome. Proc Am Thorac Soc 4: 489-493 [Full Text]
Ma, Y., HayGlass, K. T., Becker, A. B., Fan, Y., Yang, X., Basu, S., Srinivasan, G., Simons, F. E. R., Halayko, A. J., Peng, Z. (2007). Novel Recombinant Interleukin-13 Peptide-based Vaccine Reduces Airway Allergic Inflammatory Responses in Mice. Am. J. Respir. Crit. Care Med. 176: 439-445 [Abstract] [Full Text]
Hryniewicz-Jankowska, A., Choudhary, P. K., Goodman, S. R. (2007). Variation in the Monocyte Proteome. Exp. Biol. Med. 232: 967-976 [Abstract] [Full Text]
Kallinich, T., Beier, K. C., Wahn, U., Stock, P., Hamelmann, E. (2007). T-cell co-stimulatory molecules: their role in allergic immune reactions. Eur Respir J 29: 1246-1255 [Abstract] [Full Text]
Turato, G., Baraldo, S., Zuin, R., Saetta, M. (2007). The laws of attraction: chemokines, neutrophils and eosinophils in severe exacerbations of asthma. Thorax 62: 465-466 [Full Text]
Osawa, Y., Yim, P. D., Xu, D., Panettieri, R. A., Emala, C. W. (2007). Raf-1 kinase mediates adenylyl cyclase sensitization by TNF-{alpha} in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1414-L1421 [Abstract] [Full Text]
Wechsler, M. E., Shepard, J.-A. O., Mark, E. J. (2007). Case 15-2007 -- A 20-Year-Old Woman with Asthma and Cardiorespiratory Arrest. NEJM 356: 2083-2091 [Full Text]
Malbec, O., Roget, K., Schiffer, C., Iannascoli, B., Dumas, A. R., Arock, M., Daeron, M. (2007). Peritoneal Cell-Derived Mast Cells: An In Vitro Model of Mature Serosal-Type Mouse Mast Cells. J. Immunol. 178: 6465-6475 [Abstract] [Full Text]
Bradding, P. (2007). Mast cell regulation of airway smooth muscle function in asthma. Eur Respir J 29: 827-830 [Full Text]
An, S. S., Bai, T. R., Bates, J. H. T., Black, J. L., Brown, R. H., Brusasco, V., Chitano, P., Deng, L., Dowell, M., Eidelman, D. H., Fabry, B., Fairbank, N. J., Ford, L. E., Fredberg, J. J., Gerthoffer, W. T., Gilbert, S. H., Gosens, R., Gunst, S. J., Halayko, A. J., Ingram, R. H., Irvin, C. G., James, A. L., Janssen, L. J., King, G. G., Knight, D. A., Lauzon, A. M., Lakser, O. J., Ludwig, M. S., Lutchen, K. R., Maksym, G. N., Martin, J. G., Mauad, T., McParland, B. E., Mijailovich, S. M., Mitchell, H. W., Mitchell, R. W., Mitzner, W., Murphy, T. M., Pare, P. D., Pellegrino, R., Sanderson, M. J., Schellenberg, R. R., Seow, C. Y., Silveira, P. S. P., Smith, P. G., Solway, J., Stephens, N. L., Sterk, P. J., Stewart, A. G., Tang, D. D., Tepper, R. S., Tran, T., Wang, L. (2007). Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 29: 834-860 [Abstract] [Full Text]
Barnes, P. J. (2007). Unexpected Failure of Anti-Tumor Necrosis Factor Therapy in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 175: 866-867 [Full Text]
Moore, W. C., Peters, S. P. (2007). Update in Asthma 2006. Am. J. Respir. Crit. Care Med. 175: 649-654 [Full Text]
McCann, K. L., Imani, F. (2007). Transforming Growth Factor {beta} Enhances Respiratory Syncytial Virus Replication and Tumor Necrosis Factor Alpha Induction in Human Epithelial Cells. J. Virol. 81: 2880-2886 [Abstract] [Full Text]
Amrani, Y. (2007). TNF-{alpha} and Calcium Signaling in Airway Smooth Muscle Cells: A Never-Ending Story with Promising Therapeutic Relevance. Am. J. Respir. Cell Mol. Bio. 36: 387-388 [Full Text]
Pavord, I. D (2007). Non-eosinophilic asthma and the innate immune response. Thorax 62: 193-194 [Full Text]
Allakhverdi, Z., Comeau, M. R., Jessup, H. K., Yoon, B.-R. P., Brewer, A., Chartier, S., Paquette, N., Ziegler, S. F., Sarfati, M., Delespesse, G. (2007). Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. JEM 204: 253-258 [Abstract] [Full Text]
Shore, S. A. (2007). Obesity and asthma: lessons from animal models. J. Appl. Physiol. 102: 516-528 [Abstract] [Full Text]
Keslacy, S., Tliba, O., Baidouri, H., Amrani, Y. (2007). Inhibition of Tumor Necrosis Factor-{alpha}-Inducible Inflammatory Genes by Interferon-{gamma} Is Associated with Altered Nuclear Factor-{kappa}B Transactivation and Enhanced Histone Deacetylase Activity. Mol. Pharmacol. 71: 609-618 [Abstract] [Full Text]
Erin, E. M., Kon, O. M., Barnes, P. J., Hansel, T. T. (2007). Study of Infliximab Treatment in Asthma. Am. J. Respir. Crit. Care Med. 175: 196a-197 [Full Text]
Wenzel, S., Holgate, S. T. (2006). The Mouse Trap: It Still Yields Few Answers in Asthma. Am. J. Respir. Crit. Care Med. 174: 1173-1176 [Full Text]
Erin, E. M., Leaker, B. R., Nicholson, G. C., Tan, A. J., Green, L. M., Neighbour, H., Zacharasiewicz, A. S., Turner, J., Barnathan, E. S., Kon, O. M., Barnes, P. J., Hansel, T. T. (2006). The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-{alpha} in Asthma. Am. J. Respir. Crit. Care Med. 174: 753-762 [Abstract] [Full Text]
Trow, T. K. (2006). Clinical Year in Review I: Diagnostic Imaging, Asthma, Lung Transplantation, and Interventional Pulmonology. Proc Am Thorac Soc 3: 553-556 [Full Text]
O'Byrne, P. M. (2006). Cytokines or their antagonists for the treatment of asthma.. Chest 130: 244-250 [Abstract] [Full Text]
Oliveri, C, Polosa, R, Holgate, S T, Haworth, P H, Babu, K S, Arshad, H S (2006). Etanercept in chronic severe asthma * Authors' reply.. Thorax 61: 640-640 [Full Text]
(2006). Lucina. Arch. Dis. Child. 91: 626-626 [Full Text]
Vandivier, R. W., Henson, P. M., Douglas, I. S. (2006). Burying the Dead: The Impact of Failed Apoptotic Cell Removal (Efferocytosis) on Chronic Inflammatory Lung Disease. Chest 129: 1673-1682 [Abstract] [Full Text]
Nachman, S A (2006). Tumour necrosis factor {alpha} in refractory asthma: new insight. Thorax 61: 495-495 [Full Text]
Oliveri, C., Polosa, R., Berry, M. A., Pavord, I. D. (2006). Tumor Necrosis Factor {alpha} in Refractory Asthma.. NEJM 354: 2074-2075 [Full Text]
Pavord, I. D., Birring, S. S., Berry, M., Green, R. H., Brightling, C. E., Wardlaw, A. J. (2006). Multiple inflammatory hits and the pathogenesis of severe airway disease.. Eur Respir J 27: 884-888 [Abstract] [Full Text]
Fister, K. (2006). What's new in the other general journals.. BMJ 332: 477-478 [Full Text]
Erzurum, S. C. (2006). Inhibition of Tumor Necrosis Factor {alpha} for Refractory Asthma. NEJM 354: 754-758 [Full Text]

Comments and questions? Please contact us.